Correlation Between Recombinant Human Erythropoietin Dose and Inflammatory Status in Dialysed Patients

Abstract

Once recombinant human erythropoietin (r-HuEPO) was introduced in daily practice, huge steps were made in combating the adverse effects induced by anemia in chronic kidney disease population. Still, r-HuEPO resistance and the doses ensuring the maximum therapeutic benefit remain matters of debate. The aim of our study was to assess the correlation between the presence and the degree of inflammation and the r-HuEPO requirements in chronic dialysis patients. We conducted a 2 years prospective study on 146 patients undergoing chronic dialysis treated with r-HuEPO. Based on their average CRP (C-reactive protein) levels, obtained from repeated samplings at 3 months interval, 3 groups were formed; we noted in each group the average values of r-HuEPO prescribed to achieve the optimum hemoglobin levels according to the dialysis best practice guidelines and all the adverse effects of the therapy. A direct correlation was observed between CRP levels and r-HuEPO requirements in the first 2 groups of patients (CRP under 6 mg/L and CRP values 6-20 mg/L), with significant increase in r-HuEPO doses between groups (p [ 0.001); the third group, CRP values over 20 mg/dL, showed a minor, insignificant increase in average r-HuEPO doses compared to mild inflammation group (p = 0.199) and more adverse effects of the therapy (p [ 0.05). Inflammation is an important determinant of anemia in chronic dialysis patients and can induce an increase in the doses of r-HuEPO. However, prescribing excessive r-HuEPO doses is not the answer in severe inflammatory status, due to lack of response and possible adverse effects.

Incidence of Iron Deficiency and the Role of Intravenous Iron Use in Perioperative Periods

“…One of the most sensitive tools for iron deficiency diagnosis is a serum ferritin level under 30 ng/mL, which is an expression of the depleted iron stores. Nevertheless, ferritin is also released when inflammation is present like in inflammatory bowel disease, autoimmune disease, or chronic renal failure, so normal, or elevated value does not always exclude iron deficiency [ 14 , 15 ]. Another important test is represented by transferrin saturation (TSAT), which measures the transported iron that is available for cell uptake but the reliability of TSAT in measuring iron status can also be reduced by a high inflammatory status [ 13 ].…”

Ureteral JJ Stent � Which One is Better?

“…chronic kidney disease, diabetes mellitus, malnutrition etc.) [36][37][38]. Urothelial hyperplasia, stent biofilm formation and encrustation, ureteral mobility and response to ureteral intraluminal foreign-body stimuli still represents major complications that are not fully understood.…”

Postmenopausal Calcium and Vitamin D Supplements Controversy: Do They Increase Cardiovascular Risk?

“…(RANKL -receptor activator of nuclear factor kappa-B ligand, TNFα-tumor necrosis factor alpha, TRAIL -tumor necrosis factor-related apoptosis-inducing ligand, RUNX2 -runt-related transcription factor 2, SMC -smooth muscle cells, CV -cardiovascular) significant decrease of both osteoclast-like SMCs and macrophages in calcified lesions. This emphasizes the close relationship between inflammation, calcification and bone formation in the vasculature [36][37][38][39].…”